There were a couple negative things in the 10-k I
Post# of 15624
(Total Views: 285)
Posted On: 04/18/2017 8:56:06 PM
There were a couple negative things in the 10-k I was surprised to see, but I'm not sure my interpretation is correct so I've emailed the company tonight. There are a lot of good things that I took from the 10-k and my speculation leads me to believe this:
After reading the 10-k, I'm confident they are definatley looking for a big pharma company buyout or partnership. Possibly why Teva is selling woman's health to have cash to get into this expanding industry. OWCP has plenty of connections with Teva, I really look for an announcement in that direction by year end.
We all know our stock price at that time will be heading north of $5 with all our products, and if multiple myeloma moves to orphan drug status we're moving to $15 per share.
After reading the 10-k, I'm confident they are definatley looking for a big pharma company buyout or partnership. Possibly why Teva is selling woman's health to have cash to get into this expanding industry. OWCP has plenty of connections with Teva, I really look for an announcement in that direction by year end.
We all know our stock price at that time will be heading north of $5 with all our products, and if multiple myeloma moves to orphan drug status we're moving to $15 per share.
(1)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼